| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.205 | 43.119 | 73.784 | 78.213 | 73.785 | 3.570 | 21.303 | 83.409 | 59.713 | 108.879 |
| Total Income - EUR | 25.215 | 43.120 | 73.785 | 78.214 | 73.786 | 3.570 | 21.303 | 83.410 | 59.713 | 108.880 |
| Total Expenses - EUR | 17.610 | 31.832 | 56.814 | 70.113 | 82.426 | 1.812 | 22.262 | 70.971 | 58.760 | 93.880 |
| Gross Profit/Loss - EUR | 7.605 | 11.288 | 16.971 | 8.101 | -8.640 | 1.758 | -959 | 12.439 | 953 | 15.000 |
| Net Profit/Loss - EUR | 6.880 | 10.857 | 16.233 | 7.319 | -9.377 | 1.651 | -1.598 | 9.987 | 446 | 12.842 |
| Employees | 1 | 2 | 3 | 3 | 3 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Prorenal Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.879 | 7.489 | 6.400 | 4.938 | 3.660 | 2.508 | 1.324 | 1.736 | 17.042 | 14.781 |
| Current Assets | 7.244 | 6.127 | 13.228 | 6.516 | 8.312 | 493 | 4.338 | 10.807 | 8.311 | 11.648 |
| Inventories | 104 | 108 | 241 | 244 | 397 | 389 | 273 | 462 | 319 | 319 |
| Receivables | 4.120 | 4.316 | 5.184 | 4.942 | 3.864 | 0 | 3.026 | 6.462 | 6.692 | 11.170 |
| Cash | 3.020 | 1.703 | 7.803 | 1.331 | 4.051 | 104 | 1.039 | 3.883 | 1.300 | 159 |
| Shareholders Funds | 6.828 | 10.910 | 16.286 | 7.370 | -2.150 | -458 | -2.046 | 7.935 | 8.357 | 21.152 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.295 | 2.752 | 3.389 | 4.138 | 14.195 | 3.459 | 7.835 | 4.737 | 19.556 | 7.278 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Prorenal Srl